Comparison of the effect of different techniques for measurement of Ki67 proliferation on reproducibility and prognosis prediction accuracy in breast cancer

Histopathology

Volumn 61, Issue 6, 2012, Pages 1134-1144

  Gudlaugsson, Einar ^a   Skaland, Ivar ^a   Janssen, Emiel A M ^a   Smaaland, Rune ^a   Shao, Zhiming ^b   Malpica, Anais ^c   Voorhorst, Feja ^d   Baak, Jan P A ^a,b  

^a STAVANGER UNIVERSITY HOSPITAL   (Norway)

^b FUDAN UNIVERSITY SHANGHAI CANCER CENTER   (China)

^c UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^d VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Breast cancer; Digital image analysis; Ki67; Prognosis; Proliferation; Quantification; Reproducibility

Indexed keywords

KI 67 ANTIGEN;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER DIAGNOSIS; CANCER STAGING; CELL PROLIFERATION; DIAGNOSTIC ACCURACY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMAGE ANALYSIS; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MORPHOMETRICS; PRIORITY JOURNAL;

ADULT; AGED; BREAST NEOPLASMS; CELL COUNT; CELL PROLIFERATION; DIAGNOSIS, COMPUTER-ASSISTED; DIAGNOSTIC IMAGING; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; KI-67 ANTIGEN; MIDDLE AGED; PROGNOSIS; REGRESSION ANALYSIS; REPRODUCIBILITY OF RESULTS;

EID: 84870388235     PISSN: 03090167     EISSN: 13652559     Source Type: Journal    
DOI: 10.1111/j.1365-2559.2012.04329.x     Document Type: Article

References (20)

1. Veronesi U, Boyle P, Goldhirsch A et al. Breast cancer. Lancet 2005; 365; 1727-1741.
2. Adjuvant! Available at: http://www.adjuvantonline.com (accessed 26 July 2011).
3. Boyages J, Chua B, Taylor R et al. Use of the St Gallen classification for patients with node-negative breast cancer may lead to overuse of adjuvant chemotherapy. Br. J. Surg. 2002; 89; 789-796.
4. Early Breast Cancer Trialists' Collaborative Group. Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomized trials. Lancet 2005; 365; 1687-1717.
5. Lende TH, Janssen EA, Gudlaugsson E et al. In patients younger than age 55years with lymph node-negative breast cancer, proliferation by mitotic activity index is prognostically superior to Adjuvant!J. Clin. Oncol. 2011; 29; 852-858.
6. Penault-Llorca F, Andrè F, Sagan C et al. Ki67 expression and docetaxel efficacy in patients with estrogen receptor-positive breast cancer. J. Clin. Oncol. 2009; 27; 2809-2815.
7. Baak JP. The framework of pathology: good laboratory practice by quantitative and molecular methods. J. Pathol. 2002; 198; 277-283.
8. de Azambuja E, Cardoso F, de Castro G et al. Ki-67 as prognostic marker in early breast cancer: a meta-analysis of published studies involving 12155 patients. Br. J. Cancer 2007; 96; 1504-1513.
9. McShane LM, Atman DG, Sauerbrei W et al. Reporting recommendations for tumour marker studies. J. Clin. Oncol. 2005; 23; 9067-9072.
10. Tavassoli FA, Devilee P eds. Pathology and genetics: tumours of the breast and female genital tract organs. WHO classification of tumours series. Lyon: IARC Press, 2003; 9-112.
11. Ellis IO, Schnitt SJ, Sastre-Garau X et al. Invasive breast carcinoma. In Tavassoli FA, Devilee P eds. Pathology and genetics of the female genital tract organ. Lyon: IARC Press, 2003; 18-19.
12. Haybittle JL, Blamey RW, Elston CW et al. A prognostic index in primary breast cancer. Br. J. Cancer 1982; 45; 361-366.
13. Skaland I, Janssen EA, Gudlaugsson E et al. Validating the prognostic value of proliferation measured by PPH3 (phosphohistone H3) in invasive lymph node-negative breast cancer patients less than 71years of age. Breast Cancer Res. Treat. 2009; 115; 39-45.
14. Skaland I, Janssen EAM, Gudlaugsson E et al. Phosphohistone H3 expression has much stronger prognostic value than classical prognosticators in invasive lymph node-negative breast cancer patients less than 55years of age. Mod. Pathol. 2007; 20; 1307-1315.
15. Goldstein DJ. Aspects of scanning microdensitometry. I. Stray light (glare). J. Microsc. 1970; 92; 1-16.
16. Elias H, Hyde DM. An elementary introduction to stereology (quantitative microscopy). Am. J. Anat. 1980; 159; 412-446.
17. Baak JP. Manual of quantitative pathology in cancer diagnosis and prognosis. Berlin, Heidelberg, New York: Springer-Verlag, 1991.
18. Gundersen HJ, Jensen EB. The efficiency of systemic sampling in stereology and its prediction. J. Microsc. 1987; 147; 229-263.
19. Polkowski W, Meijer GA, Baak JP et al. Reproducibility of p53 and Ki-67 immunoquantitation in Barrett's esophagus. Anal. Quant. Cytol. Histol. 1997; 19; 246-254.
20. Weidner N, Semple JP, Welch WR, Folkman J. Tumor angiogenesis and metastases-correlation in invasive breast carcinoma. N. Engl. J. Med. 1991; 324; 1-8.